Starpharma Holdings Limited
SPHRY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -29.5% | 40.2% | -75.9% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -43% | -93% | -201.6% | 89.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -130.6% | -216.5% | -403.4% | -36.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -134.3% | -222.2% | -412% | -14.4% |
| EPS Diluted | -0.055 | -0.13 | -0.17 | -0.025 |
| % Growth | 57.7% | 23.5% | -580% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |